Noor Ul Ain | Genetics | Best Researcher Award

Dr. Noor Ul Ain | Genetics | Best Researcher Award

Institute of Biomedical and Genetic Engineering | Pakistan

Noor Ul Ain is a highly accomplished molecular biologist whose academic journey reflects consistent excellence from her undergraduate studies in medical laboratory technology through advanced training in biochemistry, molecular biology, and culminating in a doctorate in molecular biology. Her professional career spans significant roles as a medical laboratory technologist at Shaukat Khanum Cancer Memorial Hospital, scientific officer, and later senior scientific officer at the Institute of Biomedical and Genetic Engineering in Islamabad, as well as a visiting PhD researcher at the Karolinska Institutet in Sweden. Her research interests focus on the genetics of rare skeletal disorders, genetic susceptibility to disease outcomes such as COVID, and broader studies in molecular genetics and clinical genomics. Skilled in a wide range of laboratory and analytical techniques, including next-generation sequencing, whole exome and genome data analysis, sanger sequencing, cell culture, cloning, immunofluorescence, and microscopy, she has contributed to numerous international publications with impactful findings in human genetics and molecular pathology. She has been recognized with several prestigious awards and scholarships, including distinctions for academic performance and international research fellowships. Noor Ul Ain stands out as a promising researcher whose contributions bridge clinical relevance with molecular discovery, and her dedication positions her as a leading figure in advancing genetic and biomedical sciences..

Profile: ORCID

Featured Publications

Qura Ain | Phamagenetics | Women Researcher Award

Dr. Qura Ain | Phamagenetics | Women Researcher Award

University College Dublin | Pakistan

Dr. Qura Tul Ain is a passionate pharmacogenetic researcher and medical doctor with a strong dedication to advancing knowledge in rare diseases, human genetics, and advanced health sciences. She completed her MBBS from the Services Institute of Medical Sciences in Lahore, where she gained extensive clinical exposure through rotations in medicine, surgery, intensive care, gynecology, and ophthalmology, and later pursued an MPhil in Pharmacology with a specialization in molecular genetics at Shifa Tameer-e-Millat University, Islamabad. Her academic training provided her with expertise in genomics, bioinformatics, and molecular pharmacology, with her thesis focusing on the pharmacogenetics of low-dose empagliflozin in patients with heart failure. Professionally, she has served as a demonstrator in pharmacology at Shifa College of Medicine, alongside clinical roles as a medical officer and house physician in both medicine and surgical departments. Her research interests include pharmacogenomics, molecular genetics, and personalized medicine, with a particular focus on identifying genetic markers that predict treatment outcomes in cardiovascular diseases. She is skilled in laboratory techniques such as PCR, RFLP, DNA/RNA extraction, and gel electrophoresis, which support her translational research. Her contributions have been recognized through research fellowships and academic opportunities, reflecting her commitment to bridging genetics and clinical therapeutics. With her strong foundation in medicine, research, and teaching, Dr. Qura Tul Ain is well positioned to make impactful contributions to precision medicine and healthcare innovation.

Profile: ORCID

Featured Publications

Chengfang Tang | Newborn Screening | Best Researcher Award

Mrs. Chengfang Tang | Newborn Screening | Best Researcher Award

Guangzhou Medical University | China

Chengfang Tang, a supervising technician at Guangzhou Newborn Screening Center, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, holds a Master’s degree from Sun Yat-sen University with specialization in instrumental analysis in Pharmaceutical Analysis. With extensive professional experience, she has dedicated her career to clinical and research work on tandem mass spectrometry for newborn screening of multiple genetic metabolic diseases, contributing significantly to early detection and management of rare disorders. She also serves as Secretary of the Genetic Metabolism Group of the Rare Disease Branch of the Guangdong Medical Association, reflecting her leadership in the field. Her research interests center on newborn screening, with notable contributions in advancing diagnostic techniques for genetic metabolic conditions. She has published impactful research in high-quality journals, including International Journal of Neonatal Screening and Clinica Chimica Acta, and has conducted studies on newborn screening for adrenoleukodystrophy. Skilled in advanced laboratory techniques, mass spectrometry applications, and clinical data interpretation, her expertise supports precision medicine and improved child health outcomes. Recognized for her commitment, she has earned professional honors through memberships and leadership roles in scientific associations. Overall, Chengfang Tang’s work exemplifies excellence in research and innovation, strengthening global newborn screening efforts and improving pediatric healthcare.

Profile: ORCID

Featured Publications

Joan Lluis Vives Corrons | Anemias Raras | Breakthrough Research Award

Prof. Joan Lluis Vives Corrons | Anemias Raras | Breakthrough Research Award

Prof. Joan-Lluis Vives-Corrons is a globally recognized expert in haematology with over five decades of experience in red cell pathology and rare anaemias. He has served as Head of the Haematology Laboratory and the Red Cell Pathology Unit at Hospital Clinic, University of Barcelona. As a pioneer in haematology standardization, he was instrumental in implementing quality control measures and advancing diagnostic techniques. A prolific researcher and educator, Prof. Vives-Corrons has authored over 500 scientific publications and coordinated major national and European projects focused on haemoglobinopathies and red blood cell enzymopathies. He founded and led the European Network for Rare and Congenital Anaemias (ENERCA), contributing significantly to policy, epidemiology, and clinical care for rare diseases. His visionary leadership has also been key in establishing newborn screening programs in Catalonia. Today, he continues his academic and research involvement as Emeritus Professor at the University of Barcelona and leader of collaborative European initiatives.

Profile

Education πŸŽ“

Prof. Vives-Corrons completed his Medicine degree with honors from the University of Barcelona in 1969 and earned his MD in 1975, followed by specialization in Haematology in 1982. His early training included fellowships at prestigious institutions, including HΓ΄pital Beaujon in Paris (1972) and The Scripps Research Institute, USA (1988). His academic tenure began in 1973 as a medical assistant at the University of Barcelona’s School of Haematology, and he was appointed Professor of Medicine in 1984. His education laid the foundation for a career focused on haematological diagnostics, molecular mechanisms of red blood cell disorders, and clinical laboratory standardization. With a strong international orientation, he integrated research, clinical care, and teaching, gaining expertise in both theoretical and practical haematology. His diverse educational background and training experiences have enabled him to foster innovation in both clinical and academic settings, influencing generations of haematologists across Spain and Europe.

Experience πŸ‘¨β€πŸ«

Prof. Vives-Corrons held key positions over a distinguished 50-year career. From 1976 to 1996, he was Head of the Haematology Laboratory at Hospital Clinic, University of Barcelona, advancing diagnostic procedures and quality assessment in haematology. He later led the Red Cell Pathology Unit (1997–2016), recognized nationally as a reference center for rare anaemias. From 2017 to 2023, he led the Red Cell Pathology and Haematopoietic Disorders Group at the Josep Carreras Institute. He currently heads the Haematology Department at the Clinical Centre for Ambulatory Medicine. He has coordinated over 35 research projects, 90% as Principal Investigator, focusing on hereditary anaemias, molecular diagnostics, and epidemiology. His leadership in creating external quality assessment programs and coordinating the Catalan newborn screening program for Sickle Cell Disease marks his impactful public health contributions. Additionally, he has extensively contributed to academic training and was instrumental in establishing ENERCA for rare anaemia networking across Europe.

Awards & Recognitions πŸ…

Prof. Vives-Corrons is the recipient of numerous national and international honors. He served as Secretary General of the International Society of Hematology (1988–1998) and was appointed member of the EU Committee of Experts on Rare Diseases (EUCERD). He contributed to the development of ISO/EN 15189, a global standard for clinical laboratory quality. As principal investigator, he led European Commission-funded ENERCA projects and co-developed Catalonia’s sickle cell screening program. His leadership in launching the Catalan Network for major haemoglobinopathies earned recognition for improving patient care and public health policy. He is an active member of top scientific societies including ASH, ISH, ISLH, and the Spanish Society of Hematology. His editorial roles span key journals like Haematologica and Orphanet Journal of Rare Diseases. With over 500 peer-reviewed publications and pioneering work in rare anaemias, his contributions have been instrumental in transforming haematology research, diagnosis, and clinical protocols across Europe.

Research Interests πŸ”¬

Prof. Vives-Corrons’s research centers on red blood cell pathology, particularly congenital and acquired haemolytic anaemias. He has extensively investigated the physiopathology, genetic basis, and molecular mechanisms of rare anaemias, including G6PD and pyruvate kinase deficiencies, haemoglobinopathies like thalassaemia and sickle cell disease, and membrane disorders such as hereditary spherocytosis. His work has led to the discovery of novel genetic mutations in alpha globin and enzyme-deficiency genes. He also pioneered automation and standardization in haematology laboratories and was instrumental in creating Spain’s first EQAS system. His broader focus includes developing European collaborative networks (e.g., ENERCA) to improve diagnosis, treatment access, and epidemiological tracking of rare anaemias. He is a strong advocate of translational research, integrating laboratory discoveries into clinical applications. His efforts have helped establish molecular diagnostics and newborn screening as public health priorities in rare disease management, contributing significantly to patient care, education, and healthcare policy across Europe.

Publications
  • Angastiniotis M, Vives Corrons JL, Soteriades ES, Eleftheriou A. The impact of migrations on the health services
    for rare diseases in Europe: the example of haemoglobin disorders. ScientificWorldJournal.;2013:727905, 2013
  • Vives-Corrons JL, Briggs C, Simon-Lopez R, Albarede S, de la Salle B, Flegar-Meatrii Z, Nazor A, Guyard A, Lipsic T,
    Nagai Y, Patiu M, Piqueras J, Capel MJ, Van Blerk M, Wang J, Marzac C. Effect of EDTA-anticoagulated whole
    blood storage on cell morphology examination. A need for standardization. Int J Lab Hematol. 36(2):222-6, 2014
  • Vives-Corrons JL, Koralkova P, Grau JM, MaΓ±ΓΊ Pereira Mdel M, Van Wijk R First description of
    fosphofructokinase deficiency in spain: identification of a novel homozygous missense mutation in the PFKM
    gene. Front Physiol. 30;4:393, 2013
  • MaΓ±ΓΊ-Pereira Mdel M, Gonzalez-Roca E, van Solinge WW, Llaudet-Planas E, Sevilla J, Montllor L, Mensa-Vilaro
    A, Ploos van Amstel HK, van Wijk R, Vives-Corrons J. Pyruvate kinase deficiency and severe congenital hemolytic
    anemia in a double heterozygous patient with paternal transmission of an early germ-line de novo mutation.
    Am J Hematol. 90(12):E217-9, 2015
  • Garcia-Gomez M, Calabria A, Garcia-Bravo M, Benedicenti F, Kosinski P, LΓ³pez-Manzaneda S, Hill C, Del Mar
    MaΓ±u-Pereira M, MartΓ­n MA, Orman I, Vives-Corrons JL, Kung C, Schambach A, Jin S, Bueren JA, Montini E,
    Navarro S, Segovia JC. Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency. Mol Ther. 24(7):1187-98,
    2016

Engy Risha | Clinical Pathology | Best Researcher Award

Dr. Engy Risha | Clinical Pathology | Best Researcher Award

Prof. Engy Fikry Mohamed Hassan Risha is the Vice Dean for Education and Student Affairs at Mansoura University – Faculty of Veterinary Medicine, Clinical Pathology. She has contributed 75 research publications in clinical pathology and veterinary sciences. With a strong academic background, she has held multiple administrative and academic positions, including Head of the Clinical Pathology Department (2015-2022). She has received numerous awards, including the Best PhD Thesis Award (2011) and International Publications Incentive Awards (2013-present). She actively participates in quality assurance, course standardization, and accreditation processes at her faculty. Additionally, she serves as a reviewer for several prestigious journals in veterinary and environmental sciences. Prof. Engy is proficient in clinical hematology, clinical chemistry, immunology, and molecular biology techniques. She has international research experience in Germany and expertise in statistical analysis, immunohistochemistry, and avian clinical pathology.

Profile

Education πŸŽ“

πŸ“Œ PhD in Clinical Pathology – Mansoura University, Egypt (2010)
πŸ“Œ Master’s Degree in Clinical Pathology – Mansoura University, Egypt (2004)
πŸ“Œ Bachelor of Veterinary Sciences (Honors) – Mansoura University, Egypt (2000)

Prof. Engy has progressively advanced through academic ranks, demonstrating excellence in veterinary clinical pathology. Her PhD research was part of a joint internal mission program between Hannover and Egypt (2008-2009), enhancing her expertise in molecular biology, histology, and immunological techniques. She has also undergone specialized training in avian clinical pathology, clinical hematology, chemistry, and immunology. Additionally, she holds an ICDL certification from UNESCO (2006), reflecting her strong computer skills for academic and research applications.

Experience πŸ‘¨β€πŸ«

πŸ”Ή Vice Dean for Education and Student Affairs – Mansoura University (2022-2025)
πŸ”Ή Head of Clinical Pathology Department – Mansoura University (2015-2022)
πŸ”Ή Professor of Clinical Pathology – Mansoura University (2020-Present)
πŸ”Ή Assistant Professor of Clinical Pathology – Mansoura University (2015-2020)
πŸ”Ή Lecturer of Clinical Pathology – Mansoura University (2010-2015)
πŸ”Ή Assistant Lecturer – Mansoura University (2004-2010)
πŸ”Ή Demonstrator – Mansoura University (2001-2004)

She has significant expertise in immunohistochemistry, tissue culture, quantitative PCR, and virus infection assays from her research tenure at the University of Veterinary Medicine Hannover, Germany (2008-2009). She is also skilled in statistical analysis (t-test, ANOVA) and photographic histological documentation.

Research Interests πŸ”¬

πŸ”¬ Clinical Pathology – Hematology, Chemistry, Immunology
πŸ”¬ Molecular Biology – Quantitative PCR, Virus Titration, Immunofluorescence
πŸ”¬ Histopathology & Immunohistochemistry – Antigen Retrieval Techniques, Tissue Culture
πŸ”¬ Avian Clinical Pathology – Veterinary Diagnostic Applications
πŸ”¬ Statistical Analysis – t-test, ANOVA, Data Interpretation

Prof. Engy has 75 research publications in high-impact journals, covering clinical and molecular pathology applications. She is an active reviewer for international journals such as Environmental Toxicology and Pharmacology, Applied Organometallic Chemistry, and the Polish Journal of Veterinary Sciences. She also plays a key role in strategic planning, curriculum development, and accreditation for veterinary education. πŸš€

Awards & Recognitions πŸ…

πŸ… Best PhD Thesis Award – Mansoura University (2011)
πŸ… International Publications Incentive Award – Mansoura University (2013-present)
πŸ… PhD Joint Internal Mission Program – Hannover & Egypt (2008-2009)

Prof. Engy has been recognized for her outstanding contributions to veterinary medicine and research, particularly in clinical pathology. Her international research collaboration has significantly contributed to advancing veterinary diagnostic techniques.

PublicationsΒ